Works Cited

1. World Health Organization. Milestones in Health Promotion: Statements from Global Conferences. Available at https://www.who.int/healthpromotion/Milestones_Health_Promotion_05022010.pd. Last accessed June 15, 2021.

2. Young LE. Transforming health promotion practice: moving toward holistic care. In: Young LE, Hayes V (eds). Transforming Health Promotion Practice: Concepts, Issues and Applications. Philadelphia, PA: F.A. Davis Company; 2002.

3. West LA, Cole S, Goodkind D, He W. 65+ in the United States: 2010. Available at https://www.census.gov/content/dam/Census/library/publications/2014/demo/p23-212.pdf. Last accessed June 15, 2021.

4. United States Census Bureau. Facts for Features: Older Americans Month: May 2017. Available at https://www.census.gov/newsroom/facts-for-features/2017/cb17-ff08.html. Last accessed June 15, 2021.

5. Ortman JM, Velkoff VA, Hogan H. An Aging Nation: The Older Population in the United States. Available at https://www.census.gov/prod/2014pubs/p25-1140.pdf. Last accessed June 15, 2021.

6. Population Reference Bureau. Fact Sheet: Aging in the United States. Available at https://www.prb.org/resources/fact-sheet-aging-in-the-united-states/. Last accessed June 15, 2021.

7. Administration for Community Living. Minority Aging. Available at https://www.acl.gov/aging-and-disability-in-america/data-and-research/minority-aging. Last accessed June 15, 2021.

8. National Cancer Institute. Breast Cancer Risk in American Women. Available at https://www.cancer.gov/types/breast/risk-fact-sheet. Last accessed June 15, 2021.

9. American Cancer Society. Breast Cancer Facts and Figures 2021. Available at https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2021.html. Last accessed June 15, 2021.

10. National Institutes of Health Office of Research on Women's Health. Moving into the Future with New Dimensions and Strategies for Women's Health Research: A Vision for 2020 for Women's Health Research. Available at https://orwh.od.nih.gov/sites/orwh/files/docs/ORWH_StrategicPlan2020_Vol1.pdf. Last accessed June 15, 2021.

11. U.S. Department of Health and Human Services. Healthy People 2030. Available at https://health.gov/healthypeople/objectives-and-data/browse-objectives/women. Last accessed June 17, 2021.

12. MacDonald MA. Health promotion: historical, philosophical, and theoretical perspectives. In: Young LE, Hayes VE (eds). Transforming Health Promotion Practice: Concepts Issues and Applications. Philadelphia, PA: F.A. Davis Company; 2002: 22-45.

13. U.S. Department of Health and Human Services. Pap and HPV Tests. Available at https://www.womenshealth.gov/a-z-topics/pap-hpv-tests. Last accessed June 15, 2021.

14. Centers for Disease Control and Prevention. Cervical Cancer. What Do My Cervical Cancer Screening Test Results Mean? Available at https://www.cdc.gov/cancer/cervical/basic_info/test-results.htm. Last accessed June 15, 2021.

15. Centers for Disease Control and Prevention. Sexually Transmitted Infections Prevalence, Incidence, and Cost Estimates in the United States. Available at https://www.cdc.gov/std/statistics/prevalence-incidence-cost-2020.htm. Last accessed June 15, 2021.

16. Walensky RP, Houry D, Jernigan DB, Bunnell R, Layden J, Iademarco MF. Sexually transmitted infections treatment guidelines, 2021. MMWR. 2021;70(4):1-192.

17. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2019. Available at https://www.cdc.gov/std/. Last accessed June 15, 2021.

18. Youngkin EQ, Davis MS, Schadewald D, Juve C. Women's Health: A Primary Care Clinical Guide. 4th ed. Upper Saddle River, NJ: Prentice Hall; 2012.

19. Mitsui M, Tsukahara Y. STD and mother to child transmission. Nihon Rinsho. 2009;67(1):177-184.

20. Tjaden P, Thoennes N. Extent, Nature, and Consequences of Rape Victimization: Findings from the National Violence Against Women Survey. Available at https://www.ncjrs.gov/pdffiles1/nij/210346.pdf. Last accessed June 15, 2021.

21. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401(1):70-79.

22. Berman NR. Human papillomavirus and cervical cancer screening: recent advances improve the clinical picture. Adv Nurse Pract. 2002;10(10):26-35.

23. U.S. Food and Drug Administration. FDA News Release: FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 through 45 years old. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old. Last accessed June 15, 2021.

24. National Cancer Institute. Human Papillomavirus (HPV) Vaccines. Available at https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet. Last accessed June 15, 2021.

25. Meites E, Szilagyi PG, Chesson HW, et al. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR. 2019;68(32):698-702.

26. Centers for Disease Control and Prevention. Genital Herpes—CDC Fact Sheet. Available at https://www.cdc.gov/std/Herpes/STDFact-Herpes.htm. Last accessed June 15, 2021.

27. Chan PD. Obstetrics and Gynecology, 2011 Edition. Laguna Hills, CA: Current Clinical Strategies; 2011.

28. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350(1):11-20.

29. LexiComp Online. Available at https://online.lexi.com. Last accessed June 15, 2021.

30. Centers for Disease Control and Prevention. Trichomoniasis Statistics. Available at https://www.cdc.gov/std/trichomonas/stats.htm. Last accessed June 15, 2021.

31. Centers for Disease Control and Prevention. Trichomoniasis—CDC Fact Sheet. Available at https://www.cdc.gov/std/trichomonas/stats.htm. Last accessed June 15, 2021.

32. Centers for Disease Control and Prevention. Sexually Transmitted Diseases. Data and Statistics. Available at https://www.cdc.gov/std/statistics/default.htm. Last accessed June 15, 2021.

33. Centers for Disease Control and Prevention. Syphilis—CDC Fact Sheet. Available at https://www.cdc.gov/std/syphilis/STDFact-Syphilis.htm. Last accessed June 15, 2021.

34. Cottrell BH. Vaginal douching. J Obstet Gynecol Neonatal Nurs. 2003;32(1):12-18.

35. Cottrell BH. An updated review of the evidence to discourage douching. MCN Am J Matern Child Nurs. 2010;35(2):102-107.

36. Taber's Online. Available at http://www.tabers.com/tabersonline/ub. Last accessed June 15, 2021.

37. Centers for Disease Control and Prevention. Bacterial Vaginosis—CDC Fact Sheet. Available at https://www.cdc.gov/std/BV/STDFact-Bacterial-Vaginosis.htm. Last accessed June 15, 2021.

38. Quan M. Vaginitis: diagnosis and management. Postgrad Med. 2010;122(6):117-127.

39. Mashburn J. Etiology, diagnosis, and management of vaginitis. J Midwifery Womens Health. 2006;51(6):423-430.

40. MedlinePlus. Pap Test. Available at https://medlineplus.gov/ency/article/003911.htm. Last accessed June 15, 2021.

41. Perkins RB, Guido RS, Castle PE, et al. ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24:102-131

42. American Cancer Society. About Cervical Cancer. Key Statistics for Cervical Cancer. Available at https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html. Last accessed June 15, 2021.

43. American Cancer Society. Survival Rates for Cervical Cancer, by Stage. Available at https://www.cancer.org/cancer/cervical-cancer/detection-diagnosis-staging/survival.html. Last accessed June 15, 2021.

44. Centers for Disease Control and Prevention. National Center for Health Statistics. Pap Tests. Pap Test Use. Health, United States, 2019, Table 34. Available at https://www.cdc.gov/nchs/fastats/pap-tests.htm. Last accessed June 15, 2021.

45. Wong QC, Collins R, Kalkstein K, Roth A, Gintautas J. Cervical cancer screening among elderly urban women in a primary care setting. Proc West Pharmacol Soc. 2005;48:154-156.

46. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med. 2007;45(2-3):93-106.

47. Freeman H, Wingrove B. Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities. Rockville, MD: National Cancer Institute; 2005.

48. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Available at https://www.cdc.gov/cancer/nbccedp. Last accessed June 15, 2021.

49. Mayo Clinic. Cervical Cancer. Available at https://www.mayoclinic.org/diseases-conditions/cervical-cancer/symptoms-causes/syc-20352501. Last accessed June 15, 2021.

50. Frank JE. The colposcopic examination. J Midwifery Womens Health. 2008;53(5):447-452.

51. Haghighi F, Ghanbarzadeh N, Ataee M, Sharifzadeh G, Mojarrad JS, Najafi-Semnani F. A comparison of liquid-based cytology with convention Papanicolaou smears in cervical dysplasia diagnosis. Adv Biomed Res. 2016;5:162.

52. Seibers AG, Klinkhamer PJ, Grefte JM, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA. 2009;302(16):1757-1764.

53. Department of Health and Human Services. P080015:Cervista HPV 16/18. Available at https://www.accessdata.fda.gov/cdrh_docs/pdf8/P080015A.pdf. Last accessed June 15, 2021.

54. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Lower Genital Tract Dis. 2020;24(2):102-131.

55. U.S. Food and Drug Administration. Nucleic Acid Based Tests. Available at https://www.fda.gov/medical-devices/in-vitro-diagnostics/nucleic-acid-based-tests. Last accessed June 15, 2021.

56. U.S. Preventive Services Task Force. Final Recommendation Statement, Cervical Cancer: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening. Last accessed June 15, 2021.

57. Centers for Disease Control and Prevention. Human Papillomavirus (HPV) Vaccine Safety. Available at https://www.cdc.gov/vaccinesafety/vaccines/hpv-vaccine.html. Last accessed June 15, 2021.

58. U.S. Food and Drug Administration. Vaccines, Blood and Biologics: Gardasil. Available at https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil. Last accessed June 15, 2021.

59. U.S. Food and Drug Administration. Vaccines, Blood and Biologics: Cervarix. Available at https://www.fda.gov/vaccines-blood-biologics/vaccines/cervarix. Last accessed June 15, 2021.

60. U.S. Food and Drug Administration. FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 through 45 Years Old. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old. Last accessed June 15, 2021.

61. Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Acta Cytologica. 2015;59:121-132.

62. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114-2119.

63. American Cancer Society. Risk Factors for Cervical Cancer. Available at https://www.cancer.org/cancer/cervical-cancer/causes-risks-prevention/risk-factors.html. Last accessed June 15, 2021.

64. Kinsey Institute. FAQs and Sex Information. Available at https://kinseyinstitute.org/research/faq.php. Last accessed June 15, 2021.

65. American Cancer Society. Treating Cervical Cancer. Available at https://www.cancer.org/cancer/cervical-cancer/treating.html. Last accessed June 15, 2021.

66. National Cancer Institute. Cervical Cancer Treatment (PDQ). Available at https://www.cancer.gov/types/cervical/patient/cervical-treatment-pdq#section/all. Last accessed June 15, 2021.

67. Carlson KJ, Eisenstat SA, Frigoletto FJ Jr, Schiff I (eds). Primary Care of Women. 2nd ed. St. Louis, MO: Mosby; 2002.

68. American Cancer Society. Endometrial Cancer. Available at https://www.cancer.org/cancer/endometrial-cancer.html. Last accessed June 15, 2021.

69. Allen KM, Phillips JM. Women's Health Across the Lifespan: A Comprehensive Perspective. Philadelphia, PA: Lippincott Williams & Wilkins; 1997.

70. Banno K, Susumu N, Yanokura M, et al. Association of HNPCC and endometrial cancers. Int J Clin Oncol. 2004;9(4):262-269.

71. American Cancer Society. Ovarian Cancer. Available at https://www.cancer.org/cancer/ovarian-cancer.html. Last accessed June 15, 2021.

72. American Cancer Society. Chemotherapy for Ovarian Cancer. Available at https://www.cancer.org/cancer/ovarian-cancer/treating/chemotherapy.html. Last accessed June 15, 2021.

73. American Cancer Society. Can Ovarian Cancer Be Prevented? Available at https://www.cancer.org/cancer/ovarian-cancer/causes-risks-prevention/prevention.html. Last accessed June 15, 2021.

74. Ekwall E, Ternestedt BM, Sorbe B. Important aspects of health care for women with gynecological cancer. Oncol Nurs Forum. 2003;30(2):313-319.

75. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr. 2005;147(6):753-760.

76. Pritham UA. Managing PMS and PMDD. Exploring new treatment options. Nurs Womens Health. 2002;6(5):430-437.

77. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol. 2001;14(1):3-8.

78. Mayo Clinic. Premenstrual Syndrome (PMS). Available at https://www.mayoclinic.org/diseases-conditions/premenstrual-syndrome/symptoms-causes/syc-20376780. Last accessed June 15, 2021.

79. Mayo Clinic. Menopause. Available at https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397. Last accessed June 15, 2021.

80. George SA. The menopause experience: a woman's perspective. J Obstet Gynecol Neonatal Nurs. 2006;31(1):77-85.

81. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33.

82. Women's Health Initiative. Available at https://www.nhlbi.nih.gov/science/womens-health-initiative-whi. Last accessed June 15, 2021.

83. National Institutes of Health. Clinical Alert: NIH Asks Participants in Women's Health Initiative Estrogen-Alone Study to Stop Study Pills, Begin Follow-Up Phase. Available at https://www.nlm.nih.gov/databases/alerts/estrogen_alone.html. Last accessed June 15, 2021.

84. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative memory study. JAMA. 2004;291(24):2947-2958.

85. Bruckner MC, Youngkin EQ. What's a woman to do? Exploring HRT questions raised by the women's health initiative. Nurs Womens Health. 2002;6(5):408-417.

86. Agency for Healthcare Research and Quality. Menopausal Symptoms: Comparative Effectiveness of Therapies. Available athttps://effectivehealthcare.ahrq.gov/topics/menopause/research. Last accessed June 15, 2021.

87. National Breast Cancer Foundation. Breast Self-Exam (BSE). Available at http://www.nationalbreastcancer.org/breast-self-exam. Last accessed June 15, 2021.

88. Owens DK, U.S. Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer. US Preventive Services Task Force recommendation statement. JAMA. 2019;322(7):652-665.

89. National Cancer Institute. Breast Cancer Prevention (PDQ): Overview. Available at https://www.cancer.gov/types/breast/hp/breast-prevention-pdq#section/all. Last accessed June 15, 2021.

90. National Cancer Institute. BRCA Gene Mutations: Cancer Risk and Genetic Testing. Available at https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet#what-do-brca1-andnbspbrca2-genetic-test-results-mean. Last accessed June 15, 2021.

91. American Cancer Society. Understanding a Breast Cancer Diagnosis. Available at https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis.html. Last accessed June 15, 2021.

92. National Cancer Institute. Breast Cancer Screening (PDQ). Available at https://www.cancer.gov/types/breast/hp/breast-screening-pdq#section/all. Last accessed June 15, 2021.

93. Oeffinger KC, Fontham ETH, Etzioni R, et al. Breast cancer screening for women at average risk. 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599-1614.

94. The American College of Obstetricians and Gynecologists. Practice bulletin no. 179: breast cancer risk assessment and screening in average-risk women (Reaffirmed 2019). Obstet Gynecol. 2017;179(130):e1-e16.

95. U.S. Preventive Services Task Force. Final Recommendation Statement. Breast Cancer: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening. Last accessed June 15, 2021.

96. National Cancer Institute. Breast Changes and Conditions. Available at https://www.cancer.gov/types/breast/breast-changes. Last accessed June 15, 2021.

97. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-726.

98. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75-89.

99. American Cancer Society. Press Release: American Cancer Society Responds to Changes to USPSTF Mammography Guidelines. Available at http://pressroom.cancer.org/releases?item=201. Last accessed June 15, 2021.

100. Breastcancer.org. Treatment and Side Effects. Available at https://www.breastcancer.org/treatment. Last accessed June 15, 2021.

101. American Cancer Society. Treating Breast Cancer. Available at https://www.cancer.org/cancer/breast-cancer/treatment.html. Last accessed June 15, 2021.

102. National Cancer Institute. Breast Cancer Treatment (PDQ). Available at https://www.cancer.gov/types/breast/hp/breast-treatment-pdq. Last accessed June 15, 2021.

103. Gonzalez-Angulo AM, Buzdar AU, Hortobagyi GN. Primary systemic therapy for operable breast cancer: present role and perspectives. In: Bonodonna G, Hortobagyi GN, Valagussa P (eds). Textbook of Breast Cancer: A Clinical Guide to Therapy. 3rd ed. London: Taylor and Francis Group; 2006.

104. Perez EA. Conventional adjuvant chemotherapy: where are we 30 years later? In: Bonodonna G, Hortobagyi GN, Valagussa P (eds). Textbook of Breast Cancer: A Clinical Guide to Therapy. 3rd ed. London: Taylor and Francis Group; 2006.

105. Breastcancer.org. What is Hormonal Therapy? Available at https://www.breastcancer.org/treatment/hormonal/what_is. Last accessed June 15, 2021.

106. Visvanathan K, Chlebowski RT, Hurley P, et al. American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.J Clin Oncol. 2009;27(19):3235-3258.

107. Singer CF, Kostler WJ, Hudelist G. Predicting the efficacy of trastuzumab-based therapy in breast cancer: current standards and future strategies. Biochim Biophys Acta. 2008;1786(2):105-113.

108. National Collaborating Centre for Cancer. Early and Locally Advanced Breast Cancer: Diagnosis and Treatment. London: National Institute for Health and Clinical Excellence; 2009.

109. National Cancer Institute. Trastuzumab. Available at https://www.cancer.gov/about-cancer/treatment/drugs/trastuzumab. Last accessed June 15, 2021.

110. Gonzalez-Angulo AM, Hortobagyi GN, Esteva FJ. Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer. Oncologist. 2006;11(8):857-867.

111. Petrelli F, Coinu A, Borgonovo K, et al. The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat. 2014;144(2):223-232.

112. Li Z, Qiu Y, Lu W, Jiang Y, Wang J. Immunotherapeutic interventions of triple negative breast cancer. J Transl Med. 2018;16(1): 147.

113. Jia H, Truica CI, Wang B, et al. Immunotherapy for triple-negative breast cancer: existing challenges and exciting prospects.Drug Resist Updat. 2017;32:1-15.

114. Kwa MJ, Adams S. Checkpoint inhibitors in triple-negative breast cancer (TNBC): where to go from here. Cancer. 2018;124(10): 2086-2103.

115. U.S. Food and Drug Administration. FDA News Release: FDA Approves New Treatment Option for Patients With HER2-Positive Breast Cancer Who Have Progressed on Available Therapies. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-option-patients-her2-positive-breast-cancer-who-have-progressed-available. Last accessed June 15, 2021.

116. Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805-816.

117. National Cancer Institute. Hormone Therapy for Breast Cancer. Available at https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet. Last accessed June 15, 2021.

118. American Cancer Society. Breast Reconstruction Surgery. Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery.html. Last accessed June 15, 2021.

119. National Cancer Institute. Surgery to Reduce the Risk of Breast Cancer. Available at https://www.cancer.gov/types/breast/risk-reducing-surgery-fact-sheet. Last accessed June 15, 2021.

120. American Cancer Society. Breast Reconstruction Using Your Own Tissues (Flap Procedures). Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery/breast-reconstruction-options/breast-reconstruction-using-your-own-tissues-flap-procedures.html. Last accessed June 15, 2021.

121. Wagner LH, Ruth-Sahd LA. Pregnancy after a TRAM flap procedure: principles of nursing care. J Obstet Gynecol Neonatal Nurs. 2000;29(4):363-368.

122. Mayo Clinic. Breast Reconstruction with Flap Surgery. Available at https://www.mayoclinic.org/tests-procedures/breast-reconstruction-flap/about/pac-20384937. Last accessed June 15, 2021.

123. American Cancer Society. Breast Reconstruction Using Implants. Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery/breast-reconstruction-options/breast-reconstruction-using-implants.html. Last accessed June 15, 2021.

124. U.S. Food and Drug Administration. Acellular Dermal Matrix (ADM) Products Used in Implant-Based Breast Reconstruction Differ in Complication Rates: FDA Safety Communication. Available at https://www.fda.gov/medical-devices/safety-communications/acellular-dermal-matrix-adm-products-used-implant-based-breast-reconstruction-differ-complication. Last accessed June 15, 2021.

125. American Cancer Society. Should I Get Breast Reconstruction Surgery? Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery/should-i-get-breast-reconstruction-surgery.html. Last accessed June 15, 2021.

126. Breastcancer.org. TRAM Flap Reconstruction: What to Expect. Available at https://www.breastcancer.org/treatment/surgery/reconstruction/types/autologous/tram/what-to-expect. Last accessed June 15, 2021.

127. American Cancer Society. What to Expect After Breast Reconstruction Surgery. Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery/what-to-expect-after-breast-reconstruction-surgery.html. Last accessed June 15, 2021.

128. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-1717.

129. National Cancer Institute. Extended Adjuvant Therapy Beneficial for Some women with Breast Cancer. Available at https://www.cancer.gov/news-events/cancer-currents-blog/2016/adjuvant-aromatase-breast. Last accessed June 15, 2021.

130. Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008;9(1):45-53.

131. Joy AA. San Antonio Breast Cancer Symposium 2007—adjuvant endocrine therapy update: ATAC 100 highlights. Curr Oncol. 2008;15(1):68-69.

132. Zhou J, Wu SG, Wang JJ, et al. Ovarian ablation using goserelin improves survival of premenopausal patients with stage II/III hormone receptor-positive breast cancer without chemotherapy-induced amenorrhea. Cancer Res Treat. 2015;47(1):55-63.

133. Zhang P, Li CZ, Jiao GM, et al. Effects of ovarian ablation or suppression in premenopausal breast cancer: a meta-analysis of randomized controlled trials. Eur J Surg Oncol. 2017;43(7):1161-1172.

134. Eisen A, Breast Cancer Disease Site Group. Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women With Early Stage Invasive Breast Cancer. Available at https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/1031. Last accessed June 15, 2021.

135. Tevaarwerk AJ, Wang M, Zhao F, et al. Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2014;32(35):3948-3958.

136. Roux G, Dingley CE, Bush HB. Inner strength in women: metasynthesis of qualitative findings in theory development. J Theory Construction Testing. 2002;6(1):86-93.

137. Murphy SL, Xu J, Kochanek KD, Arias E, Tejada-Vera B. Deaths: final data for 2018. Natl Vital Stat Rep. 2021;69(13):1-83.

138. Maxson J. Remedying dyslipidemia NCEP-ATP III strategies to slow CVD. Clin Rev. 2002;12(10):53-60.

139. Womenshealth.gov. Heart Disease and Women Fact Sheet. Available at https://owh-wh-d9-dev.s3.amazonaws.com/s3fs-public/documents/fact-sheet-heart-disease-and-women.pdf. Last accessed June 15, 2021.

140. American Heart Association. Facts: Cardiovascular Disease: Women's No. 1 Health Threat. Available at http://www.heart.org/idc/groups/heart-public/@wcm/@adv/documents/downloadable/ucm_302256.pdf. Last accessed June 15, 2021.

141. Penque S, Halm M, Smith M, et al. Women and coronary disease: relationship between descriptors of signs and symptoms and diagnostic and treatment course. Am J Crit Care. 1998;7(3):175-182.

142. Clouse AL, Sherif K. Women's Health in Clinical Practice: A Handbook for Primary Care. Totowa, NJ: Humana Press; 2008.

143. Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights From the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21-S29.

144. Pepine CJ, Kerensky RA, Lambert CR, et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol. 2006;47(3 Suppl):S30-S35.

145. National Heart, Lung, and Blood Institute. What Are the Risk Factors for Heart Disease? Available at https://www.nhlbi.nih.gov/health-topics/education-and-awareness/heart-truth. Last accessed June 15, 2021.

146. Fryar CD, Carroll MD, Ogden CL. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960–1962 through 2011–2012. Available at https://www.cdc.gov/nchs/data/hestat/obesity_adult_11_12/obesity_adult_11_12.htm. Last accessed June 15, 2021.

147. Womenshealth.gov. Top Questions About Fitness and Women Fact Sheet. Available at https://owh-wh-d9-dev.s3.amazonaws.com/s3fs-public/documents/fact-sheet-fitness-and-women.pdf. Last accessed June 15, 2021.

148. Kealy MM. Preventing obesity. Nurs Womens Health. 2003;7(1):24-27.

149. Tipton KD, Wolfe RR. Exercise, protein metabolism, and muscle growth. Int J Sport Nutr Exerc Metab. 2001;11(1):109-132.

150. Souhami RL, Moxham J. Textbook of Medicine. 4th ed. Philadelphia, PA: Elsevier Health Sciences; 2002.

151. Oliver JE. Fat Politics: The Real Story Behind America's Obesity Epidemic. New York, NY: Oxford University Press; 2006.

152. Mehta T, Smith DL Jr, Muhammad J, Casazza K. Impact of weight cycling on risk of morbidity and mortality. Obes Rev. 2014;15(11):870-881.

153. U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd Edition. Available at https://health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf. Last accessed June 15, 2021.

154. Thompson PD, Buchner D, Piña IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107(24):3109-3116.

155. U.S. Department of Agriculture. MyPlate. Available at https://www.myplate.gov/. Last accessed June 15, 2021.

156. National Institutes of Health Office of Dietary Supplements. Calcium: Fact Sheet for Health Professionals. Available at https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional. Last accessed June 15, 2021.

157. Dudek SG. Nutrition Handbook for Nursing Practice. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.

158. Womenshealth.gov. Iron-Deficiency Anemia Fact Sheet. Available at https://www.womenshealth.gov/a-z-topics/iron-deficiency-anemia?from=AtoZ. Last accessed June 15, 2021.

159. International Food Information Council Foundation. Everything You Need to Know About the Functions of Fats in Foods. Available at https://foodinsight.org/wp-content/uploads/2009/10/FatsInFoods-Single.pdf. Last accessed June 15, 2021.

160. American Heart Association. The American Heart Association Diet and Lifestyle Recommendations. Available at https://www.heart.org/en/healthy-living/healthy-eating/eat-smart/nutrition-basics/aha-diet-and-lifestyle-recommendations#.WywPjOS0WIV. Last accessed June 15, 2021.

161. Erickson JD. Folic acid and prevention of spinal bifida and anencephaly: 10 years after the U.S. Public Health Service recommendation. MMWR. 2002;51(RR13):1-3.

162. U.S. Department of Health and Human Services, U.S. Department of Agriculture. Dietary Guidelines for Americans, 2020-2025. Available at https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf. Last accessed June 15, 2021.

163. The Cleveland Clinic. Diabetes Mellitus: An Overview. Available at https://my.clevelandclinic.org/health/diseases/7104-diabetes-mellitus-an-overview. Last accessed June 15, 2021.

164. U.S. Food and Drug Administration. FDA News Release: FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014. Last accessed June 15, 2021.

165. Centers for Disease Control and Prevention. Diabetes Data and Statistics. Available at https://www.cdc.gov/diabetes/data/index.html. Last accessed June 15, 2021.

166. Centers for Disease Control and Prevention. Diabetes Tests. Available at https://www.cdc.gov/diabetes/basics/getting-tested.html. Last accessed June 15, 2021.

167. American Diabetes Association. Standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Suppl 1): S1-S232.

168. National Osteoporosis Foundation. What is Osteoporosis and What Causes It? Available at https://www.nof.org/patients/what-is-osteoporosis. Last accessed June 15, 2021.

169. Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis – 2020 Update. Endocr Pract. 2020;26(Suppl 1):1-46.

170. Womenshealth.gov. Osteoporosis Fact Sheet. Available at https://www.womenshealth.gov/a-z-topics/osteoporosis?from=AtoZ. Last accessed June 15, 2021.

171. MedlinePlus. Menopause. Available at https://medlineplus.gov/menopause.html. Last accessed June 15, 2021.

172. Office of the Surgeon General. Report of the Surgeon General's Workshop on Osteoporosis and Bone Health: December 12–13, 2002. Washington, DC. Rockville, MD: Office of the Surgeon General; 2003.

173. Research America. Osteoporosis and Hip Fractures. Available at https://cdn.nof.org/wp-content/uploads/2017/02/OsteoporosisHip-Fracture_2017.pdf. Last accessed June 15, 2021.

174. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis. Available at https://www.bones.nih.gov/health-info/bone/osteoporosis. Last accessed June 15, 2021.

175. National Institutes of Health. Calcium and Vitamin D: Important at Every Age. Available at https://www.bones.nih.gov/health-info/bone/bone-health/nutrition/calcium-and-vitamin-d-important-every-age. Last accessed June 15, 2021.

176. Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014;9(11):e111265.

177. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7):CD007470.

178. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014;1:CD007470.

179. Terushkin V, Bender A, Psaty EL, Engelsen O, Wang SQ, Halpern AC. Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two U.S. latitudes. J Am Acad Dermatol. 2010;62(6):929.e1-e9.

180. Adami S, Idolazzi L, Rossini M. Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review. Ther Adv Musculoskelet Dis. 2011;3(2):67-79.

181. U.S. Food and Drug Administration. FDA Drug Safety Communication: Ongoing Safety Review of Oral Osteoporosis Drugs (Bisphosphonates) and Potential Increased Risk of Esophageal Cancer. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-ongoing-safety-review-oral-osteoporosis-drugs-bisphosphonates-and. Last accessed June 15, 2021.

182. U.S. Food and Drug Administration. FDA Approves New Treatment for Osteoporosis in Postmenopausal Women at High Risk of Fracture. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-osteoporosis-postmenopausal-women-high-risk-fracture. Last accessed June 15, 2021.

183. World Health Organization. Mental Health. Available at https://www.who.int/news-room/facts-in-pictures/detail/mental-health. Last accessed June 15, 2021.

184. U.S. Preventive Services Task Force. Depression in Adults: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-adults-screening. Last accessed June 15, 2021.

185. National Institute of Mental Health. Depression. Available at https://www.nimh.nih.gov/health/topics/depression/. Last accessed June 15, 2021.

186. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.

187. Zung WW. The role of rating scales in the identification and management of the depressed patient in the primary care setting.J Clin Psychiatry. 1990;(51 Suppl):72-76.

188. National Center for Injury Prevention and Control. WISQARS Leading Causes of Death Reports, National and Regional, 1999–2019. Available at https://webappa.cdc.gov/sasweb/ncipc/leadcause.html. Last accessed June 15, 2021.

189. National Institute of Mental Health. Suicide Prevention. Available at https://www.nimh.nih.gov/health/topics/suicide-prevention/. Last accessed June 15, 2021.

190. Anxiety and Depression Association of America. Facts and Statistics. Available at https://adaa.org/about-adaa/press-room/facts-statistics. Last accessed June 15, 2021.

191. National Institute of Mental Health. Anxiety Disorders. Available at https://www.nimh.nih.gov/health/topics/anxiety-disorders/. Last accessed June 15, 2021.

192. Uphold CR, Graham MV. Clinical Guidelines in Family Practice. 4th ed. Gainesville, FL: Barmarrae Books; 2003.

193. American Psychiatric Association. Intimate Partner Abuse and Relationship Violence. Available at https://www.apa.org/about/division/activities/partner-abuse.pdf. Last accessed June 15, 2021.

194. U.S. Preventive Services Task Force. Intimate Partner Violence and Abuse of Elderly and Vulnerable Adults: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening. Last accessed June 15, 2021.

195. Sprague S, Madden K, Dosanjh S, Petrisor B, Schemitsch EH, Bhandari M. Screening for intimate partner violence in orthopedic patients: a comparison of three screening tools. J Interpers Violence. 2012;27(5):881-898.

196. Children's Defense Fund. The State of America's Children 2021. Available at https://www.childrensdefense.org/wp-content/uploads/2021/04/The-State-of-Americas-Children-2021.pdf. Last accessed June 15, 2021.

197. Centers for Disease Control and Prevention. Patterns of Unintentional Injuries among 0-19 Year Olds in the United States, 2000–2006. Available at https://www.cdc.gov/safechild/images/CDC-ChildhoodInjury.pdf. Last accessed June 15, 2021.

198. National Rifle Association. Safety Programs: Eddie Eagle. Available at https://eddieeagle.nra.org. Last accessed June 15, 2021.

199. Lipari RN, Van Horn SL. The CBHSQ Short Report. Children Living With Parents Who Have a Substance Use Disorder. Available at https://www.samhsa.gov/data/sites/default/files/report_3223/ShortReport-3223.html. Last accessed June 15, 2021.

200. National Institute on Drug Abuse. Health Consequences of Drug Misuse. Available at https://www.drugabuse.gov/publications/health-consequences-drug-misuse/death. Last accessed June 15, 2021.

201. D'Amico EJ, Paddock SM, Burnam A, Kung FY. Identification of and guidance for problem drinking by general medical providers: results from a national survey. Med Care. 2005;43(3):229-236.

202. Becker KL, Walton-Moss B. Detecting and addressing alcohol abuse in women. Nurse Pract. 2001;26(10):13-16, 19-23.

203. Ewing, JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252(14):1905-1907.

204. Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156(6):607-614.

205. Dhalla S, Zumbo BD, Poole G. A review of the psychometric properties of the CRAFFT instrument: 1999–2010. Curr Drug Abuse Rev. 2011;4(1):57-64.

206. Running A, Berndt A. Management Guidelines for Nurse Practitioners Working in Family Practice. Philadelphia, PA: F.A. Davis Company; 2003.

207. Martin AC, Schaeffer SD, Campbell R. Managing alcohol-related problems in the primary care setting. Nurse Pract. 1999;24(8): 14-39.

208. National Institute on Drug Abuse. DrugFacts: Lessons from Prevention Research. Available at https://www.drugabuse.gov/publications/drugfacts/lessons-prevention-research. Last accessed June 15, 2021.

209. The Office of Research on Women's Health: National Institutes of Health. Women of Color: Health Data Book. Available at https://orwh.od.nih.gov/sites/orwh/files/docs/WoC-Databook-FINAL.pdf. Last accessed June 15, 2021.

210. American Heart Association. African Americana and Heart Disease, Stroke. Available at https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease/african-americans-and-heart-disease-stroke. Last accessed June 15, 2021.

211. American College of Cardiology. Cardiovascular Risk Factors Appear Early in Black Women Under Age 40. Available at https://www.acc.org/about-acc/press-releases/2021/05/04/17/21/cardiovascular-risk-factors-appear-early-in-black-women. Last accessed June 15, 2021.

212. Mosca L, Hammond G, Mochari-Greenberger H, et al. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation. 2013;127(11):1254-1263, e1-e29.

213. Centers for Disease Control and Prevention. Women and Stroke. Available at https://www.cdc.gov/stroke/women.htm. Last accessed June 15, 2021.

214. Centers for Disease Control and Prevention. WISEWOMAN. Available at https://www.cdc.gov/wisewoman. Last accessed June 15, 2021.

215. Office of Minority Health. Profile: Black/African Americans. Available at https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlID=61. Last accessed June 15, 2021.

216. Lynch EB, Kane J. Body size perception among African American women. J Nutr Educ Behav. 2014;46(5):412-417.

217. Der Ananian C, Winham DM, Thompson SV, Tisue ME. Perceptions of heart-healthy behaviors among African American adults: a mixed methods study. Int J Environ Res Public Health. 2018;15(11):2433.

218. Winham DM, Jones KM. Knowledge of young African American adults about heart disease: a cross-sectional survey. BMC Public Health. 2011;11:248.

219. Cunningham TJ, Croft JB, Liu Y, Lu H, Eke PI, Giles WH. Vital signs: racial disparities in age-specific mortality among blacks or African Americans—United States, 1999–2015. MMWR. 2017;66(17):444-456.

220. Wilson DK, Alia KA, Kitzman-Ulrich H, Resnicow K. A pilot study of the effects of a tailored web-based intervention on promoting fruit and vegetable intake in African American families. Child Obes. 2014;10(1):77-84.

221. Office of Minority Health. Profile: American Indian/Alaska Native. Available at https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlid=62. Last accessed June 15, 2021.

222. Office of Minority Health. Profile: Hispanic/Latino Americans. Available at https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlid=64. Last accessed June 15, 2021.

223. Office of Minority Health. Cancer and Hispanic Americans. Available at https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=61. Last accessed June 15, 2021.

224. Cancer Action Network. Cervical Cancer Incidence Rates Remain Higher in Hispanic/Latina Women. Available at https://www.fightcancer.org/sites/default/files/FINAL%20-%20Hispanic%20Latinas%20and%20Cervical%20Cancer%2005.09.17.pdf. Last accessed June 15, 2021.

225. Asian Women for Health. Asian Americans and Cancer Fact Sheet. Available at https://www.asianwomenforhealth.org/asian-womens-health.html. Last accessed June 15, 2021.

226. Juon HS, Seung-Lee C, Klassen AC (2003). Predictors of regular Pap smears among Korean American women. Prevent Med. 2003;37(6):585–592.

227. Taylor VM, Yasui Y, Burke N, et al. Pap testing adherence among Vietnamese American women. Cancer Epidemiol Biomarkers Prev. 2004;13(4):613–619.

228. Mokuau N, Braun KL. Family support for Native Hawaiian women with breast cancer. J Cancer Educ. 2007;22(3):191-196.

229. Ka`opua LS. Developing a culturally responsive breast cancer screening promotion with Native Hawaiian women in churches. Health Soc Work. 2008;33(3):169-177.

230. Bourgette-Henry SJ, Davis A, Flood J, Choi SY, Bourgette A. The Wahine Heart Wellness Program: a community approach to reducing women's cardiovascular disease risk. Hawaii J Health Soc Welf. 2019;78(11):341-348.

231. Dossey BM, Keegan L. Holistic Nursing: A Handbook for Practice. 5th ed. Sudbury, MA: Jones and Bartlett Publishers; 2009.

232. Kisling LA, Stiegmann RA. Alternative Medicine. Treasure Island, FL: StatPearls Publishing; 2021.

233. National Center for Complementary and Integrative Health. Available at https://nccih.nih.gov. Last accessed June 15, 2021.

234. MedlinePlus. Dong Quai. Available at https://medlineplus.gov/druginfo/natural/936.html. Last accessed June 15, 2021.

235. MedlinePlus. Evening Primrose Oil. Available at https://nccih.nih.gov/health/eveningprimrose. Last accessed June 15, 2021.

236. American Holistic Nurses Association. Available at https://www.ahna.org/. Last accessed June 15, 2021.

237. Buckle J. Clinical aromatherapy: therapeutic uses for essential oils. Adv Nurse Pract. 2002;10(5):67-68, 88.

238. MedlinePlus. Lavender. Available at https://nccih.nih.gov/health/lavender/ataglance.htm. Last accessed June 15, 2021.

239. Goldberg B, Goldberg MA. Alternative Medicine: The Definitive Guide. 2nd ed. Berkeley, CA: Ten Speed Press; 2002.

240. Simonton OC, Creighton J, Matthews S. Getting Well Again. Reissue. New York, NY: Bantam Books; 1992.

241. Harsora P, Kessman J. Nonpharmacologic management of chronic insomnia. Am Fam Physician. 2009;79(2):125-130.

242. National Center for Complementary and Integrative Health. Mediation: In Depth. Available at https://www.nccih.nih.gov/health/meditation-in-depth. Last accessed June 15, 2021.

244. National Center for Complementary and Integrative Health. Yoga: What You Need to Know. Available at https://www.nccih.nih.gov/health/yoga-what-you-need-to-know. Last accessed June 15, 2021.

245. Begley SS. The energetic language of therapeutic touch: a holistic tool for nurse practitioners. Adv Nurse Pract. 2002;10(5):69-71.

246. Mount Sinai. Therapeutic Touch. Available at https://www.mountsinai.org/health-library/treatment/therapeutic-touch. Last accessed June 15, 2021.

247. Mish FC, Copeland RD, Despres JM, Lowe JG, Pease RW Jr. Rader JL (eds). The Merriam-Webster Dictionary. 11th ed. Springfield, MA: Merriam Webster Mass Market; 2004.

248. American Speech-Language-Hearing Association. Hearing Screening. Available at https://www.asha.org/public/hearing/Hearing-Screening. Last accessed June 15, 2021.

249. Womenshealth.gov. Healthy Living by Age. Available at https://www.womenshealth.gov/healthy-living-age. Last accessed June 15, 2021.

250. U.S. Preventive Services Task Force. Thyroid Dysfunction: Screening. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/thyroid-dysfunction-screening. Last accessed June 15, 2021.

251. U.S. Preventive Services Task Force. Colorectal Cancer: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening. Last accessed June 15, 2021.

252. American Dental Association. American Dental Association Statement on Regular Dental Visits. Available at https://www.ada.org/en/press-room/news-releases/2013-archive/june/american-dental-association-statement-on-regular-dental-visits. Last accessed June 15, 2021.

253. American Optometric Association. Comprehensive Eye Exams. Available at https://www.aoa.org/healthy-eyes/caring-for-your-eyes/eye-exams?sso=y. Last accessed June 15, 2021.

254. Centers for Disease Control and Prevention. ACIP Vaccine Recommendations and Guidelines. Available at https://www.cdc.gov/vaccines/hcp/acip-recs/index.html. Last accessed June 15, 2021.

255. Centers for Disease Control and Prevention. Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States 2021. Available at https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html. Last accessed June 15, 2021.

256. Grohskopf L, Sikolow LZ, Fry AM, Walter EB, Jernigan DB. Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4)—United States, 2018–19 influenza season. MMWR. 2018;67(22):643-645.

257. U.S. Food and Drug Administration. FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 through 45 Years Old. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old. Last accessed June 15, 2021.

Evidence-Based Practice Recommendations Citations

1. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. MMWR. 2016;65(49);1405-1408. Available at https://www.cdc.gov/mmwr/volumes/65/wr/mm6549a5.htm. Last accessed July 9, 2021.

2. Walensky RP, Houry D, Jernigan DB, Bunnell R, Layden J, Iademarco MF. Sexually transmitted infections treatment guidelines, 2021. MMWR. 2021;70(4):1-192. Available at https://www.cdc.gov/std/treatment-guidelines/screening-recommendations.htm. Last accessed October 14, 2021.

3. Faculty of Sexual and Reproductive Healthcare. Contraception for Women Aged Over 40 Years. London: Faculty of Sexual and Reproductive Healthcare; 2017. Available at https://www.fsrh.org/standards-and-guidance/documents/fsrh-guidance-contraception-for-women-aged-over-40-years-2017. Last accessed July 9, 2021.

4. The North American Menopause Society. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728-753. Available at https://www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf. Last accessed July 9, 2021.

5. U.S. Preventive Services Task Force. BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing. Last accessed July 9, 2021.

6. McSweeney JC, Rosenfeld AG, Abel WM, et al. Preventing and experiencing ischemic heart disease as a woman: state of the science: a scientific statement from the American Heart Association. Circulation. 2016;133(13):1302-1331. Available at https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000381. Last accessed July 9, 2021.

7. Allen S, Forney-Gorman A, Homan M, Kearns A, Kramlinger A, Sauer M. Diagnosis and Treatment of Osteoporosis. Bloomington, MN: Institute for Clinical Systems Improvement; 2017. Available at https://www.icsi.org/wp-content/uploads/2019/01/Osteo.pdf. Last accessed July 9, 2021.


Copyright © 2021 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.